Table 2.

Inter-group comparisons of efficacy outcomes.

	HEC			MEC
	S group (n = 28)	R group (n = 29)	P-value	S group (n = 30)	R group (n = 32)	P-value
No emesis
Overall	26 (92.9%)	25 (86.2%)	0.41	30 (100%)	28 (90.6%)	0.06
Acute	28 (100%)	28 (96.6%)	0.51	30 (100%)	32 (100%)	1
Delayed	26 (92.9%)	25 (86.2%)	0.41	30 (100%)	28 (90.6%)	0.06
No significant nausea
Overall	18 (64.3%)	21 (72.4%)	0.51	24 (80.0%)	24 (75.0%)	0.64
Acute	28 (100%)	27 (93.1%)	0.25	29 (96.7%)	30 (93.8%)	0.52
Delayed	18 (64.3%)	21 (72.4%)	0.51	24 (80.0%)	24 (75.0%)	0.64
No nausea
Overall	16 (57.1%)	16 (55.2%)	0.88	21 (70.0%)	21 (65.6%)	0.71
Acute	26 (92.9%)	26 (89.7%)	0.52	28 (93.3%)	28 (87.5%)	0.37
Delayed	16 (57.1%)	16 (55.2%)	0.88	21 (70.0%)	21 (65.6%)	0.71
Complete response
Overall	19 (67.9%)	18 (62.1%)	0.65	25 (83.3%)	27 (84.4%)	0.59
Acute	27 (96.4%)	26 (89.7%)	0.32	30 (100%)	32 (100%)	1
Delayed	19 (67.9%)	18 (62.1%)	0.65	25 (83.3%)	27 (84.4%)	0.59
Complete protection
Overall	17 (60.7%)	18 (62.1%)	0.92	21 (70.0%)	23 (71.9%)	0.87
Acute	27 (96.4%)	26 (89.7%)	0.32	29 (96.7%)	31 (96.9%)	0.73
Delayed	17 (60.7%)	18 (62.1%)	0.92	21 (70.0%)	23 (71.9%)	0.87
Total control
Overall	15 (53.6%)	15 (51.7%)	0.68	20 (66.7%)	20 (62.5%)	0.73
Acute	26 (92.9%)	25 (86.2%)	0.35	28 (93.3%)	29 (90.6%)	0.53
Delayed	15 (53.6%)	15 (51.7%)	0.89	20 (66.7%)	20 (62.5%)	0.73